For research use only. Not for therapeutic Use.
| Catalog Number | R062960 |
| CAS Number | 1937-62-8 |
| Synonyms | 9(E)-Octadecenoic Acid Methyl Ester; Methyl 9(E)-Octadecenoate; Methyl Elaidate; Methyl trans-9-Octadecenoate; trans-Oleic Acid Methyl Ester |
| Molecular Formula | C19H36O2 |
| Purity | ≥95% |
| Storage | -20°C |
| IUPAC Name | methyl (E)-octadec-9-enoate |
| InChI | InChI=1S/C19H36O2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19(20)21-2/h10-11H,3-9,12-18H2,1-2H3/b11-10+ |
| InChIKey | QYDYPVFESGNLHU-ZHACJKMWSA-N |
| SMILES | CCCCCCCCC=CCCCCCCCC(=O)OC |
| Reference | <br>1. M. Abbey and P. Nestel “Plasma cholesteryl ester transfer protein activity is increased when trans-elaidic acid is substituted for cis-oleic acid in the diet”Atherosclerosis, Vol. 106(1) pp. 99-107, 1994<br>2. M. Ruth et al. “Vaccenic and Elaidic Acid Modify Plasma and Splenocyte Membrane Phospholipids and Mitogen-Stimulated Cytokine Production inObese Insulin Resistant JCR: LA-cp Rats” Nutrients, Vol. 2 pp. 181-197, 2010<br>3. P. Nestel et al. “Plasma lipoprotein lipid and Lp[a] changes with substitution of elaidic acid for oleic acid in the diet” Journal of Lipid Research, Vol. 33pp. 1029-1036, 1992<br>4. M. Williams et al. “Risk of Preeclampsia in Relation to Elaidic Acid (Trans Fatty Acid) in Maternal Erythrocytes” Gynecologic and ObstetricInvestigation, Vol. 46(2), 1998</br></br></br></br> |
